BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23715161)

  • 1. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall.
    Pižem J; Nicholson KM; Mraz J; Prieto VG
    Am J Surg Pathol; 2013 Aug; 37(8):1182-91. PubMed ID: 23715161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
    Kopera D; Hohenleutner U; Stolz W; Landthaler M
    Dermatology; 1997; 194(4):344-50. PubMed ID: 9252755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of TRPM1 (Melastatin) mRNA expression with microphthalmia-associated transcription factor (MITF) and other melanogenesis-related proteins in normal and pathological skin, hair follicles and melanocytic nevi.
    Lu S; Slominski A; Yang SE; Sheehan C; Ross J; Carlson JA
    J Cutan Pathol; 2010 Apr; 37 Suppl 1(Suppl 1):26-40. PubMed ID: 20482673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations.
    Nybakken GE; Sargen M; Abraham R; Zhang PJ; Ming M; Xu X
    Am J Dermatopathol; 2013 Feb; 35(1):25-9. PubMed ID: 22668579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating neurotized melanocytic nevi from neurofibromas using Melan-A (MART-1) immunohistochemical stain.
    Chen Y; Klonowski PW; Lind AC; Lu D
    Arch Pathol Lab Med; 2012 Jul; 136(7):810-5. PubMed ID: 22742554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ.
    Kim J; Taube JM; McCalmont TH; Glusac EJ
    J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
    Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
    J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of melanocytic differentiation with prognostic markers in medullary thyroid carcinomas.
    Karaarslan S; Nur Yurum F; Ebru Pala E; Ortac R; Husnu Bugdayci M
    Pathol Res Pract; 2015 May; 211(5):356-60. PubMed ID: 25475146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intradermal melanocytic nevus with prominent schwannian differentiation.
    Kroumpouzos G; Cohen LM
    Am J Dermatopathol; 2002 Feb; 24(1):39-42. PubMed ID: 11803280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics.
    Koch MB; Shih IM; Weiss SW; Folpe AL
    Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melan-A positive dermal cells in malignant melanoma in situ.
    Danga ME; Yaar R; Bhawan J
    J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
    Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
    Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma.
    Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ
    Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous epithelioid melanocytic neurofibroma arising in a patient with neurofibromatosis-1.
    Novoa RA; Kovarik CL; Low DW; Argenyi Z
    J Cutan Pathol; 2014 May; 41(5):457-61. PubMed ID: 24472086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
    Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
    Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofibromas and neurotized melanocytic nevi are immunohistochemically distinct neoplasms.
    Gray MH; Smoller BR; McNutt NS; Hsu A
    Am J Dermatopathol; 1990 Jun; 12(3):234-41. PubMed ID: 1693815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
    Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
    J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.